Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (61-70 of 953) with videos related to

Pageof 96
Sort By:
Journal of Alzheimer'S Disease : JAD|November 13, 2020
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic ReviewJ Q Alida Chen, Philip Scheltens, Colin Groot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2012
Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's diseasePieter Jelle Visser, Stephanie Vos, Ineke van Rossum, et al.
Alzheimer Disease and Associated Disorders|June 16, 2004
Memantine in moderate-to-severe Alzheimer disease evidence and ethics based?Marcel G Rikkert, Wim J Dekkers, Philip Scheltens, et al.
The Medical Clinics of North America|May 7, 2013
International Work Group criteria for the diagnosis of Alzheimer diseaseJeffrey L Cummings, Bruno Dubois, José L Molinuevo, et al.
Neuropsychologia|March 27, 2007
Subcortical white matter pathology as a mediating factor for age-related decreased performance in dichotic listeningLiselotte Gootjes, Philip Scheltens, Jan W Van Strien, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentThomas Finnegan, Frances McFarland, Austin Baiardi, et al.
Brain : a Journal of Neurology|October 28, 2005
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI studyRutger Goekoop, Philip Scheltens, Frederik Barkhof, et al.
Neuro-Degenerative Diseases|May 27, 2011
Hippocampal atrophy in subcortical vascular dementiaLaura van de Pol, Hermann-Josef Gertz, Philip Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|January 4, 2005
Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patientsPieter Jelle Visser, Philip Scheltens, Esther Pelgrim, et al.
Trials|February 25, 2010
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trialEls I S Most, Philip Scheltens, Eus J W Van Someren
Pageof 96

Showing results (61-70 of 953) with videos related to

Sort By:
Pageof 96
Journal of Alzheimer'S Disease : JAD|November 13, 2020
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic ReviewJ Q Alida Chen, Philip Scheltens, Colin Groot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2012
Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's diseasePieter Jelle Visser, Stephanie Vos, Ineke van Rossum, et al.
Alzheimer Disease and Associated Disorders|June 16, 2004
Memantine in moderate-to-severe Alzheimer disease evidence and ethics based?Marcel G Rikkert, Wim J Dekkers, Philip Scheltens, et al.
The Medical Clinics of North America|May 7, 2013
International Work Group criteria for the diagnosis of Alzheimer diseaseJeffrey L Cummings, Bruno Dubois, José L Molinuevo, et al.
Neuropsychologia|March 27, 2007
Subcortical white matter pathology as a mediating factor for age-related decreased performance in dichotic listeningLiselotte Gootjes, Philip Scheltens, Jan W Van Strien, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentThomas Finnegan, Frances McFarland, Austin Baiardi, et al.
Brain : a Journal of Neurology|October 28, 2005
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI studyRutger Goekoop, Philip Scheltens, Frederik Barkhof, et al.
Neuro-Degenerative Diseases|May 27, 2011
Hippocampal atrophy in subcortical vascular dementiaLaura van de Pol, Hermann-Josef Gertz, Philip Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|January 4, 2005
Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patientsPieter Jelle Visser, Philip Scheltens, Esther Pelgrim, et al.
Trials|February 25, 2010
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trialEls I S Most, Philip Scheltens, Eus J W Van Someren
Pageof 96